4-Bromo-2-(methoxymethyl)pyridine - CAS 864412-04-4
Catalog: |
BB057919 |
Product Name: |
4-Bromo-2-(methoxymethyl)pyridine |
CAS: |
864412-04-4 |
Synonyms: |
4-bromo-2-(methoxymethyl)pyridine; 4-bromanyl-2-(methoxymethyl)pyridine |
IUPAC Name: | 4-bromo-2-(methoxymethyl)pyridine |
Description: | 4-Bromo-2-(methoxymethyl)pyridine (cas# 864412-04-4) is a useful research chemical. |
Molecular Weight: | 202.05 |
Molecular Formula: | C7H8NOBr |
Canonical SMILES: | COCC1=NC=CC(=C1)Br |
InChI: | InChI=1S/C7H8BrNO/c1-10-5-7-4-6(8)2-3-9-7/h2-4H,5H2,1H3 |
InChI Key: | ZORPPTKICHKCHP-UHFFFAOYSA-N |
Solubility: | DMSO (Slightly), Methanol (Sparingly) |
Appearance: | Colourless Oil |
Storage: | 4°C, Inert atmosphere |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021195066-A2 | Kcnt1 inhibitors and methods of use | 20200323 |
WO-2021105481-A1 | Novel compounds for treatment of diseases related to dux4 expression | 20191129 |
IL-266931-D0 | Methods of Use of Conjugated Pyrazole and Pyrazole Compounds and Treatment of Hyperproliferative Diseases | 20161130 |
EP-3150592-A1 | Alk kinase inhibitor, and preparation method and use thereof | 20140530 |
JP-2017516825-A | ALK kinase inhibitors and methods for their preparation and use | 20140530 |
US-10023593-B2 | ALK kinase inhibitor, and preparation method and uses thereof | 20140530 |
US-2017247392-A1 | Alk kinase inhibitor, and preparation method and uses thereof | 20140530 |
WO-2015180685-A1 | Alk kinase inhibitor, and preparation method and use thereof | 20140530 |
US-2011178056-A1 | Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | 20091113 |
US-2013196966-A1 | Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | 20091113 |
Complexity: | 99.6 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 200.97893 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 200.97893 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 22.1Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[279-23-2]
Norbornane
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[1984-15-2]
Methylenediphosphonic acid
-
[169689-05-8]
1S,2S-DHAC-Phenyl Trost Ligand
-
[332360-02-8]
Mitoguazone dihydrochloride monohydrate
INDUSTRY LEADERS TRUST OUR PRODUCTS